Of the 55 patients with CAH, 36 (12/36, 33% female) were reported to have a defect in CYP21A2 and 1 male patient in HSD3B2; the genetic screening result was unavailable in 18 (7/18, 39% female) patients. This evidence concerns the gene HSD3B2 and congenital adrenal hyperplasia.